Variant report
Variant | nsv971951 |
---|---|
Chromosome Location | chr11:56345170-56361311 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:244)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr11:56349510-56349580 | Fibrobl | skin: | n/a | n/a |
2 | EP300 | chr11:56351599-56351679 | K562 | blood: | n/a | n/a |
3 | FOXA2 | chr11:56359507-56359790 | A549 | lung: | n/a | n/a |
4 | FOXA2 | chr11:56359462-56360029 | A549 | lung: | n/a | n/a |
5 | JUND | chr11:56347234-56347550 | HepG2 | liver: | n/a | chr11:56347413-56347424 |
6 | MAFK | chr11:56347260-56347559 | HepG2 | liver: | n/a | chr11:56347408-56347423 |
7 | MAFK | chr11:56347287-56347547 | HepG2 | liver: | n/a | chr11:56347408-56347423 |
8 | POLR2A | chr11:56346671-56346804 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | POLR2A | chr11:56351420-56351427 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | POLR2A | chr11:56347338-56347358 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr11:56359933-56360093 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | POLR2A | chr11:56359966-56359991 | Gliobla | brain: | n/a | n/a |
13 | POLR2A | chr11:56353553-56353647 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | STAT3 | chr11:56349086-56349198 | MCF10A-Er-Src | breast: | n/a | chr11:56349135-56349143 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:56345862-56345912 | SKMC | muscle: | n/a |
2 | chr11:56345354-56345404 | AG10803 | skin: | n/a |
3 | chr11:56345858-56345908 | NT2-D1 | testis: | n/a |
4 | chr11:56345858-56345908 | T-47D | breast: | n/a |
5 | chr11:56345140-56345190 | BJ | skin: | n/a |
6 | chr11:56345354-56345404 | CMK | blood: | n/a |
7 | chr11:56345862-56345912 | HRE | kidney: | n/a |
8 | chr11:56345140-56345190 | AG09309 | skin: | n/a |
9 | chr11:56345862-56345912 | AoSMC | blood vessel: | n/a |
10 | chr11:56345858-56345908 | HAEpiC | amniotic membrane: | n/a |
11 | chr11:56345354-56345404 | ProgFib | skin: | n/a |
12 | chr11:56345862-56345912 | GM06990 | blood: | n/a |
13 | chr11:56345862-56345912 | GM19239 | blood: | n/a |
14 | chr11:56345354-56345404 | HRCEpiC | kidney: | n/a |
15 | chr11:56345862-56345912 | NB4 | blood: | n/a |
16 | chr11:56345354-56345404 | SK-N-SH | brain: | n/a |
17 | chr11:56345354-56345404 | GM12892 | blood: | n/a |
18 | chr11:56345140-56345190 | HRPEpiC | eye: | n/a |
19 | chr11:56345862-56345912 | GM12891 | blood: | n/a |
20 | chr11:56345140-56345190 | GM12878 | blood: | n/a |
21 | chr11:56345858-56345908 | HRPEpiC | eye: | n/a |
22 | chr11:56345858-56345908 | U87 | brain: | n/a |
23 | chr11:56345354-56345404 | NB4 | blood: | n/a |
24 | chr11:56345862-56345912 | ovcar-3 | ovarian: | n/a |
25 | chr11:56345354-56345404 | Hela-S3 | cervix: | n/a |
26 | chr11:56345858-56345908 | CMK | blood: | n/a |
27 | chr11:56345858-56345908 | GM12891 | blood: | n/a |
28 | chr11:56345140-56345190 | Hepatocyte | liver: | n/a |
29 | chr11:56345858-56345908 | HEK293 | kidney: | embryo |
30 | chr11:56345354-56345404 | NHBE | bronchial: | n/a |
31 | chr11:56345862-56345912 | AG09309 | skin: | n/a |
32 | chr11:56345858-56345908 | Hela-S3 | cervix: | n/a |
33 | chr11:56345354-56345404 | HMEC | breast: | n/a |
34 | chr11:56345354-56345404 | Caco-2 | colon: | n/a |
35 | chr11:56345858-56345908 | BE2_C | brain: | n/a |
36 | chr11:56345862-56345912 | SK-N-MC | brain: | n/a |
37 | chr11:56345862-56345912 | Hepatocyte | liver: | n/a |
38 | chr11:56345862-56345912 | AG04449 | skin: | fetal |
39 | chr11:56345858-56345908 | MCF10A-Er-Src | breast: | n/a |
40 | chr11:56345862-56345912 | HEEpiC | esophagus: | n/a |
41 | chr11:56345862-56345912 | HRCEpiC | kidney: | n/a |
42 | chr11:56345858-56345908 | SKMC | muscle: | n/a |
43 | chr11:56345862-56345912 | AG04450 | lung: | fetal |
44 | chr11:56345858-56345908 | SK-N-SH_RA | brain: | n/a |
45 | chr11:56345862-56345912 | K562 | blood: | n/a |
46 | chr11:56345140-56345190 | HepG2 | liver: | n/a |
47 | chr11:56345354-56345404 | SK-N-SH_RA | brain: | n/a |
48 | chr11:56345862-56345912 | CMK | blood: | n/a |
49 | chr11:56345858-56345908 | GM06990 | blood: | n/a |
50 | chr11:56345140-56345190 | AG04450 | lung: | fetal |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR5M10 | TF binding region |
OR5M10 | CpG island |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190078336 | chr11:56345354-56345355 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs552107401 | chr11:56345378-56345379 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs540426037 | chr11:56345403-56345404 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs539043880 | chr11:56345858-56345859 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs4382928 | chr11:56345862-56345863 | Inactive region | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs572401942 | chr11:56345881-56345882 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs138905903 | chr11:56346694-56346695 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs559738629 | chr11:56346727-56346728 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs532739244 | chr11:56346759-56346760 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs528493356 | chr11:56346784-56346785 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs181468610 | chr11:56347259-56347260 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs114775376 | chr11:56347277-56347278 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs531322942 | chr11:56347337-56347338 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs138263652 | chr11:56347386-56347387 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs565554472 | chr11:56347401-56347402 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs528974434 | chr11:56347407-56347408 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs532773243 | chr11:56347443-56347444 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs547933670 | chr11:56347471-56347472 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs186055454 | chr11:56347508-56347509 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs149645917 | chr11:56347555-56347556 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs76266444 | chr11:56349087-56349088 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs181912862 | chr11:56349096-56349097 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs534303216 | chr11:56349100-56349101 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs139134025 | chr11:56349145-56349146 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs555603330 | chr11:56349147-56349148 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs190505717 | chr11:56349434-56349435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529967078 | chr11:56349443-56349444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548497903 | chr11:56349450-56349451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569909602 | chr11:56349472-56349473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12418150 | chr11:56349477-56349478 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs77413628 | chr11:56349482-56349483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553544899 | chr11:56349483-56349484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146780889 | chr11:56349496-56349497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140629603 | chr11:56349527-56349528 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs568740252 | chr11:56349547-56349548 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs565305553 | chr11:56349570-56349571 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs61902209 | chr11:56351019-56351020 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs545503474 | chr11:56351022-56351023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145802156 | chr11:56351034-56351035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555922338 | chr11:56351039-56351040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574148568 | chr11:56351055-56351056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs138616662 | chr11:56351076-56351077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575587422 | chr11:56351099-56351100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556551141 | chr11:56351154-56351155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112541069 | chr11:56351188-56351189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:56349400-56349600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr11:56351000-56351200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |